Literature DB >> 6752328

Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody.

A A Holder, R R Freeman.   

Abstract

Stage-specific protein synthesis by the erythrocytic forms of the malaria parasite Plasmodium falciparum was investigated by pulse labeling synchronous parasite cultures with [35S]methionine at 6-h intervals during a complete 48-h developmental cycle. About 40 labeled parasite proteins could be immunoprecipitated with human immune serum, and most of these were associated with the schizont stage of development. In particular, one schizont protein was a 195,000-mol wt species against which a murine monoclonal antibody was produced. This monoclonal antibody, 89.1 reacted with the parasite membrane in schizonts and also with the surface of free merozoites in the indirect immunofluorescence test. In addition to the 195,000-mol wt protein, antibody 89.1 immunoprecipitated a series of lower-molecular weight polypeptides from extracts of labeled asynchronous P. falciparum parasite cultures. These were shown to be related to the 195,000-mol wt protein by peptide mapping. Pulse-chase labeling of synchronized cultures, and immunoprecipitation with antibody 89.1, showed that specific processing of the 195,000-mol wt polypeptide to the lower-molecular-weight products in concomitant with schizont maturation and merozoite release. It is suggested that this P. falciparum protein may be analogous to a similarly processed 230,000-mol wt protective antigen of the rodent malaria parasite, P. yoelii.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752328      PMCID: PMC2186849          DOI: 10.1084/jem.156.5.1528

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Antigenic analysis of sequential erythrocytic stages of Plasmodium knowlesi.

Authors:  J A Deans; E D Dennis; S Cohen
Journal:  Parasitology       Date:  1978-12       Impact factor: 3.234

Review 3.  Acquired immunity and vaccination in malaria.

Authors:  S Cohen; G A Butcher; G H Mitchell; J A Deans; J Langhorne
Journal:  Am J Trop Med Hyg       Date:  1977-11       Impact factor: 2.345

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies.

Authors:  L H Perrin; E Ramirez; P H Lambert; P A Miescher
Journal:  Nature       Date:  1981-01-22       Impact factor: 49.962

6.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

7.  Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite.

Authors:  R R Freeman; A J Trejdosiewicz; G A Cross
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

8.  Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria.

Authors:  E H Nardin; R S Nussenzweig; I A McGregor; J H Bryan
Journal:  Science       Date:  1979-11-02       Impact factor: 47.728

9.  Synchronization of Plasmodium falciparum erythrocytic stages in culture.

Authors:  C Lambros; J P Vanderberg
Journal:  J Parasitol       Date:  1979-06       Impact factor: 1.276

10.  Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.

Authors:  P Potocnjak; N Yoshida; R S Nussenzweig; V Nussenzweig
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  87 in total

1.  In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.

Authors:  Alan L Y Pang; Caryn N Hashimoto; Leslie Q Tam; Z Q Meng; George S N Hui; Walter K K Ho
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 2.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

3.  Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development.

Authors:  D L Doolan; A J Saul; M F Good
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

4.  Induction of protective immunity to Plasmodium falciparum in Saimiri sciureus monkeys with partially purified exoantigens.

Authors:  M A James; I Kakoma; M Ristic; M Cagnard
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

5.  Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.

Authors:  P Ray; N Sahoo; B Singh; F A Kironde
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Identification and expression in Escherichia coli of merozoite stage-specific genes of the human malarial parasite Plasmodium falciparum.

Authors:  M J McGarvey; E Sheybani; M P Loche; L Perrin; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

7.  Comparison of asexual blood-stage antigens of Plasmodium falciparum recognized by antibody reagents from nine laboratories.

Authors:  R Dayal; C Decrind; P H Lambert
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

8.  Studies of murine malaria antigens using monoclonal antibodies. Production, selection, and characterization of antibodies.

Authors:  G Holmquist; P Borwell; A R Cattan; H Wigzell
Journal:  Z Parasitenkd       Date:  1986

9.  Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum.

Authors:  S P Chang; G S Hui; A Kato; W A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  Plasmodium falciparum products enhance human lymphocyte transformation by Epstein-Barr virus.

Authors:  P K Kataaha; C A Facer; E J Holborow
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.